Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 53 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of February 21, 2025 is 55.83.
  • The all-time high Bristol Myers Squibb stock closing price was 73.93 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 61.10, which is 9.4% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 39.35, which is 29.5% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 50.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 57.0738 56.7900 60.6000 53.9000 55.8300 -1.29%
2024 48.7208 50.2299 59.9400 39.0290 56.5600 15.78%
2023 58.5848 65.8478 68.4547 46.1552 48.8495 -25.49%
2022 65.6434 54.6809 73.9307 54.6809 65.5653 19.00%
2021 55.0101 52.9891 60.7434 47.3907 55.0962 2.89%
2020 51.3669 53.0089 56.4318 38.8319 53.5503 0.39%
2019 41.1920 42.0787 53.3413 35.2498 53.3413 27.86%
2018 45.8925 47.9247 54.2695 39.1333 41.7175 -12.91%
2017 44.5656 45.2381 51.0827 35.8623 47.9013 7.72%
2016 47.6300 50.0924 58.0153 37.4613 44.4695 -13.50%
2015 47.5487 43.4640 52.5552 42.3237 51.4076 19.24%
2014 37.5034 37.1326 44.4942 33.3285 43.1135 14.18%
2013 30.6149 22.5371 37.9906 22.5371 37.7577 69.95%
2012 22.3583 22.9395 24.3964 21.0032 22.2167 -3.78%
2011 18.6682 16.6231 23.1229 15.8140 23.0902 39.43%
2010 15.7608 15.4582 17.2656 13.6961 16.5606 8.74%
2009 12.6818 13.6279 15.4640 9.9926 15.2290 14.78%
2008 11.9186 14.0798 14.5917 9.7182 13.2683 -6.05%
2007 15.1323 13.6564 16.9555 13.5114 14.1224 4.75%
2006 12.1494 11.3694 13.4822 10.2512 13.4822 19.92%
2005 11.6456 11.8911 12.6592 10.2882 11.2422 -6.16%
2004 11.5572 13.2584 13.8411 10.3990 11.9799 -7.27%
2003 11.1184 10.3940 12.9196 9.1396 12.9196 29.02%
2002 12.9686 21.0718 21.2583 8.6774 10.0133 -52.36%
2001 23.4518 28.9150 28.9150 20.1940 21.0182 -29.71%
2000 23.3832 25.6336 29.9018 17.3758 29.9018 17.11%
1999 26.9738 25.6032 31.0037 22.7050 25.5341 -2.80%
1998 21.2220 18.3803 26.2707 17.4441 26.2707 42.93%
1997 14.6536 10.1994 18.9204 10.1994 18.3803 77.07%
1996 8.6040 7.8319 10.9468 7.4224 10.3804 32.15%
1995 6.2111 5.2242 7.8777 5.1471 7.8548 53.26%
1994 4.7950 4.8289 5.3007 4.3118 5.1250 6.09%
1993 4.7590 5.3048 5.3048 4.1875 4.8306 -9.48%
1992 5.5898 6.7688 6.8071 4.8654 5.3364 -21.16%
1991 5.9725 4.9556 6.7688 4.5651 6.7688 35.84%
1990 4.2999 4.0722 4.9940 3.6595 4.9831 24.56%
1989 3.4629 3.0448 4.0432 3.0187 4.0007 28.87%
1988 2.8911 2.9348 3.1214 2.6125 3.1044 9.89%
1987 3.2364 2.8625 3.7321 2.4768 2.8249 0.77%
1986 2.5679 2.2308 2.9813 2.0486 2.8032 24.71%
1985 1.9884 1.7388 2.2942 1.6879 2.2478 26.48%
1984 1.5740 1.4633 1.7812 1.4165 1.7772 23.98%
1983 1.3173 1.1366 1.6160 1.0687 1.4335 25.66%
1982 1.0083 0.8949 1.2426 0.8674 1.1408 26.57%
1981 0.8880 0.8652 0.9924 0.7826 0.9013 5.45%
1980 0.6907 0.6172 0.8716 0.5216 0.8547 36.16%
1979 0.5862 0.6043 0.6489 0.5301 0.6277 3.50%
1978 0.5713 0.5663 0.6743 0.4792 0.6065 6.31%
1977 0.5526 0.5768 0.6043 0.4898 0.5705 -1.99%
1976 0.6202 0.5874 0.7019 0.5248 0.5821 -0.36%
1975 0.5267 0.4336 0.6245 0.3997 0.5842 37.39%
1974 0.3941 0.3965 0.4761 0.2682 0.4252 8.11%
1973 0.5187 0.5810 0.6055 0.3732 0.3933 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $113.215B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $231.223B 18.14
Amgen (AMGN) United States $160.049B 15.03
Gilead Sciences (GILD) United States $137.127B 23.87
Vertex Pharmaceuticals (VRTX) United States $123.344B 0.00
CSL (CSLLY) Australia $80.117B 0.00
GSK (GSK) United Kingdom $76.602B 9.15
Regeneron Pharmaceuticals (REGN) United States $76.092B 17.53
Argenex SE (ARGX) Netherlands $39.342B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.494B 0.00
BioNTech SE (BNTX) Germany $28.261B 0.00
BeiGene (ONC) Cayman Islands $23.897B 0.00
Biogen (BIIB) United States $20.065B 8.32
Illumina (ILMN) United States $15.396B 39.67
Insmed (INSM) United States $14.958B 0.00
Genmab (GMAB) Denmark $14.850B 18.10
Genmab (GNMSF) Denmark $14.741B 15.19
Incyte (INCY) United States $13.814B 419.88
Intra-Cellular Therapies (ITCI) United States $13.667B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.099B 25.27
Moderna (MRNA) United States $12.980B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.851B 27.71
Sarepta Therapeutics (SRPT) United States $10.355B 93.46
Bio-Techne Corp (TECH) United States $10.353B 39.69
Vaxcyte (PCVX) United States $10.279B 0.00
Exelixis (EXEL) United States $9.821B 20.05
Ascendis Pharma (ASND) Denmark $9.381B 0.00
Exact Sciences (EXAS) United States $9.197B 0.00
Repligen (RGEN) United States $9.114B 109.91
Bio-Rad Laboratories (BIO.B) United States $8.741B 30.27
QIAGEN (QGEN) Netherlands $8.557B 17.26
Jazz Pharmaceuticals (JAZZ) Ireland $8.261B 8.08
Zealand Pharma (ZLDPF) Denmark $7.692B 0.00
Roivant Sciences (ROIV) United Kingdom $7.649B 0.00
Revolution Medicines (RVMD) United States $7.109B 0.00
Legend Biotech (LEGN) United States $7.108B 0.00
Halozyme Therapeutics (HALO) United States $7.074B 14.65
Axsome Therapeutics (AXSM) United States $6.296B 0.00
Cytokinetics (CYTK) United States $6.033B 0.00
Blueprint Medicines (BPMC) United States $6.030B 0.00
Telix Pharmaceuticals (TLX) Australia $5.865B 0.00
Guardant Health (GH) United States $5.856B 0.00
Nuvalent (NUVL) United States $5.854B 0.00
Alkermes (ALKS) Ireland $5.773B 14.67
Krystal Biotech (KRYS) United States $5.261B 55.01
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.253B 0.00
TG Therapeutics (TGTX) United States $4.816B 0.00
SpringWorks Therapeutics (SWTX) United States $4.458B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.326B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.114B 0.00
Biohaven (BHVN) United States $4.022B 0.00
PTC Therapeutics (PTCT) United States $3.886B 0.00
Avidity Biosciences (RNA) United States $3.881B 0.00
ADMA Biologics Inc (ADMA) United States $3.801B 40.20
Scholar Rock Holding (SRRK) United States $3.665B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.549B 0.00
Arcellx (ACLX) United States $3.548B 0.00
Akero Therapeutics (AKRO) United States $3.530B 0.00
Alvotech (ALVO) Luxembourg $3.527B 0.00
Apellis Pharmaceuticals (APLS) United States $3.527B 0.00
Viking Therapeutics (VKTX) United States $3.525B 0.00
Immunovant (IMVT) United States $3.474B 0.00
Zai Lab (ZLAB) China $3.391B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.376B 26.01
Merus (MRUS) Netherlands $3.261B 0.00
Metsera (MTSR) United States $3.260B 0.00
Denali Therapeutics (DNLI) United States $3.107B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.002B 0.00
Amicus Therapeutics (FOLD) United States $2.787B 151.17
Beam Therapeutics (BEAM) United States $2.744B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.690B 0.00
Twist Bioscience (TWST) United States $2.689B 0.00
Vericel (VCEL) United States $2.681B 905.17
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.672B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.643B 0.00
Edgewise Therapeutics (EWTX) United States $2.566B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.552B 0.00
ImmunityBio (IBRX) United States $2.536B 0.00
Kymera Therapeutics (KYMR) United States $2.424B 0.00
NovoCure (NVCR) Jersey $2.343B 0.00
Ligand Pharmaceuticals (LGND) United States $2.305B 57.55
Protagonist Therapeutics (PTGX) United States $2.294B 14.47
Mesoblast (MESO) Australia $2.189B 0.00
Certara (CERT) United States $2.181B 61.59
CG Oncology (CGON) United States $2.146B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.990B 16.54
Janux Therapeutics (JANX) United States $1.951B 0.00
Agios Pharmaceuticals (AGIO) United States $1.934B 0.00
Bavarian Nordic (BVNRY) Denmark $1.923B 11.78
IDEAYA Biosciences (IDYA) United States $1.902B 0.00
Vera Therapeutics (VERA) United States $1.875B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.862B 0.00
Travere Therapeutics (TVTX) United States $1.840B 0.00
Belite Bio (BLTE) United States $1.823B 0.00
Galapagos (GLPG) Belgium $1.761B 0.00
Dynavax Technologies (DVAX) United States $1.752B 74.06
WAVE Life Sciences (WVE) Singapore $1.728B 0.00
Ascentage Pharma Group - (AAPG) China $1.713B 0.00
Iovance Biotherapeutics (IOVA) United States $1.710B 0.00
Disc Medicine (IRON) United States $1.617B 0.00
GRAIL (GRAL) United States $1.605B 0.00
Geron (GERN) United States $1.590B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.571B 0.00
MannKind (MNKD) United States $1.561B 40.43
Apogee Therapeutics (APGE) United States $1.529B 0.00
NeoGenomics (NEO) United States $1.524B 0.00
Celldex Therapeutics (CLDX) United States $1.499B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.494B 0.00
Praxis Precision Medicines (PRAX) United States $1.482B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.422B 0.00
Fortrea Holdings (FTRE) United States $1.400B 44.60
Liquidia Technologies (LQDA) United States $1.397B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.365B 0.00
Myriad Genetics (MYGN) United States $1.364B 0.00
Vir Biotechnology (VIR) United States $1.350B 0.00
Structure Therapeutics (GPCR) United States $1.339B 0.00
Viridian Therapeutics (VRDN) United States $1.317B 0.00
Nurix Therapeutics (NRIX) United States $1.293B 0.00
Novavax (NVAX) United States $1.269B 0.00
Arvinas (ARVN) United States $1.263B 0.00
ANI Pharmaceuticals (ANIP) United States $1.255B 17.10
Intellia Therapeutics (NTLA) United States $1.248B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.233B 0.00
Adaptive Biotechnologies (ADPT) United States $1.229B 0.00
Pacira BioSciences (PCRX) United States $1.189B 11.19
Gyre Therapeutics (GYRE) United States $1.175B 0.00
89BIO (ETNB) United States $1.163B 0.00
MiMedx (MDXG) United States $1.154B 30.19
Spyre Therapeutics (SYRE) United States $1.153B 0.00
Replimune (REPL) United States $1.102B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.991B 0.00
Arcus Biosciences (RCUS) United States $0.983B 0.00
Zymeworks (ZYME) United States $0.966B 0.00
AbCellera Biologics (ABCL) Canada $0.927B 0.00
ArriVent BioPharma (AVBP) United States $0.923B 0.00
Cogent Biosciences (COGT) United States $0.894B 0.00
Oculis Holding AG (OCS) Switzerland $0.863B 0.00
Pharvaris (PHVS) Netherlands $0.863B 0.00
Sionna Therapeutics (SION) $0.855B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.829B 0.00
Prothena (PRTA) Ireland $0.821B 0.00
Immunome (IMNM) United States $0.807B 0.00
Opthea (OPT) Australia $0.768B 0.00
Nuvation Bio (NUVB) United States $0.764B 0.00
Bicara Therapeutics (BCAX) United States $0.752B 0.00
Anavex Life Sciences (AVXL) United States $0.738B 0.00
CureVac (CVAC) Germany $0.734B 5.96
Castle Biosciences (CSTL) United States $0.732B 130.75
GH Research (GHRS) Ireland $0.728B 0.00
Dianthus Therapeutics (DNTH) United States $0.701B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
LENZ Therapeutics (LENZ) United States $0.686B 0.00
Sana Biotechnology (SANA) United States $0.683B 0.00
Cytek Biosciences (CTKB) United States $0.670B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.657B 0.00
CorMedix Inc (CRMD) United States $0.657B 0.00
Arbutus Biopharma (ABUS) United States $0.652B 0.00
Tyra Biosciences (TYRA) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Kura Oncology (KURA) United States $0.634B 0.00
UniQure (QURE) Netherlands $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.609B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.600B 0.00
Absci (ABSI) United States $0.596B 0.00
Pharming Group (PHGUF) Netherlands $0.587B 0.00
Precigen (PGEN) United States $0.577B 0.00
AnaptysBio (ANAB) United States $0.574B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.556B 0.00
Immatics (IMTX) Germany $0.549B 0.00
MeiraGTx Holdings (MGTX) United States $0.534B 0.00
Cullinan Therapeutics (CGEM) United States $0.533B 0.00
Maze Therapeutics (MAZE) United States $0.533B 0.00
Oric Pharmaceuticals (ORIC) United States $0.531B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.519B 0.00
Cartesian Therapeutics (RNAC) United States $0.498B 0.00
Entrada Therapeutics (TRDA) United States $0.489B 8.22
Celcuity (CELC) United States $0.488B 0.00
Abivax SA (ABVX) France $0.483B 0.00
Rapport Therapeutics (RAPP) United States $0.475B 0.00
Mineralys Therapeutics (MLYS) United States $0.475B 0.00
Allogene Therapeutics (ALLO) United States $0.473B 0.00
Humacyte (HUMA) United States $0.472B 0.00
Chimerix (CMRX) United States $0.465B 0.00
Stoke Therapeutics (STOK) United States $0.463B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.458B 0.00
Tectonic Therapeutic (TECX) United States $0.455B 0.00
Keros Therapeutics (KROS) United States $0.447B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.445B 0.00
Upstream Bio (UPB) United States $0.441B 0.00
Sage Therapeutics (SAGE) United States $0.440B 0.00
PureTech Health (PRTC) United States $0.439B 0.00
Kamada (KMDA) Israel $0.439B 27.25
ChromaDex (CDXC) United States $0.435B 569.50
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.433B 0.00
Alpha Teknova (TKNO) United States $0.426B 0.00
Emergent Biosolutions (EBS) United States $0.425B 0.00
Compass Therapeutics (CMPX) United States $0.424B 0.00
MaxCyte (MXCT) United States $0.419B 0.00
Erasca (ERAS) United States $0.413B 0.00
Prime Medicine (PRME) United States $0.411B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.407B 0.00
Candel Therapeutics (CADL) United States $0.397B 0.00
MBX Biosciences (MBX) United States $0.395B 0.00
Astria Therapeutics (ATXS) United States $0.385B 0.00
Aura Biosciences (AURA) United States $0.381B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.379B 0.00
Eton Pharmaceuticals (ETON) United States $0.375B 0.00
ATyr Pharma (ATYR) United States $0.372B 0.00
Trevi Therapeutics (TRVI) United States $0.369B 0.00
REGENXBIO (RGNX) United States $0.365B 0.00
Terns Pharmaceuticals (TERN) United States $0.351B 0.00
Gossamer Bio (GOSS) United States $0.347B 0.00
Codexis (CDXS) United States $0.347B 0.00
Northwest Biotherapeutics (NWBO) United States $0.344B 0.00
Zenas BioPharma (ZBIO) United States $0.326B 0.00
Annexon (ANNX) United States $0.302B 0.00
Foghorn Therapeutics (FHTX) United States $0.299B 0.00
Olema Pharmaceuticals (OLMA) United States $0.291B 0.00
XOMA Royalty (XOMA) United States $0.289B 0.00
Prima BioMed (IMMP) Australia $0.287B 0.00
Design Therapeutics (DSGN) United States $0.284B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.283B 0.00
DiaMedica Therapeutics (DMAC) United States $0.283B 0.00
Rezolute (RZLT) United States $0.280B 0.00
Neumora Therapeutics (NMRA) United States $0.276B 0.00
ITeos Therapeutics (ITOS) United States $0.273B 0.00
Benitec Biopharma (BNTC) United States $0.271B 0.00
Semper Paratus Acquisition (TVGN) United States $0.271B 0.00
EnGene Holdings (ENGN) Canada $0.271B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.271B 0.00
Atea Pharmaceuticals (AVIR) United States $0.265B 0.00
AC Immune (ACIU) Switzerland $0.263B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 0.00
Septerna (SEPN) United States $0.262B 0.00
Tango Therapeutics (TNGX) United States $0.261B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.259B 0.00
Anika Therapeutics (ANIK) United States $0.258B 0.00
Neurogene (NGNE) United States $0.257B 0.00
BioStem Technologies (BSEM) $0.256B 22.60
Bright Minds Biosciences (DRUG) United States $0.255B 0.00
Abeona Therapeutics (ABEO) United States $0.253B 0.00
Urogen Pharma (URGN) United States $0.251B 0.00
Monopar Therapeutics (MNPR) United States $0.250B 0.00
Kodiak Sciences (KOD) United States $0.249B 0.00
Verastem (VSTM) United States $0.248B 0.00
Amarin (AMRN) Ireland $0.244B 0.00
Solid Biosciences (SLDB) United States $0.243B 0.00
Alumis (ALMS) United States $0.242B 0.00
Cardiff Oncology (CRDF) United States $0.240B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.236B 0.00
Sangamo Therapeutics (SGMO) United States $0.234B 0.00
Voyager Therapeutics (VYGR) United States $0.233B 6.00
ACELYRIN, INC (SLRN) United States $0.218B 0.00
Palvella Therapeutics (PVLA) United States $0.213B 0.00
Lifecore Biomedical (LFCR) United States $0.212B 0.00
C4 Therapeutics (CCCC) United States $0.211B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.211B 0.00
Fulcrum Therapeutics (FULC) United States $0.208B 0.00
Ocugen (OCGN) United States $0.204B 0.00
Contineum Therapeutics (CTNM) United States $0.204B 0.00
INmune Bio (INMB) United States $0.202B 0.00
Nautilus Biotechnology (NAUT) United States $0.201B 0.00
Molecular Partners AG (MOLN) Switzerland $0.198B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.198B 0.00
GENFIT S.A (GNFT) France $0.196B 0.00
Compugen (CGEN) Israel $0.195B 109.00
Innate Pharma S.A (IPHA) France $0.189B 0.00
Adocia (ADOCY) France $0.187B 0.00
Inhibrx Biosciences (INBX) United States $0.185B 0.00
Pliant Therapeutics (PLRX) United States $0.183B 0.00
Alector (ALEC) United States $0.182B 0.00
Adherex Technologies (FENC) United States $0.182B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.179B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.176B 0.00
Fate Therapeutics (FATE) United States $0.176B 0.00
Editas Medicine (EDIT) United States $0.170B 0.00
CARGO Therapeutics (CRGX) United States $0.170B 0.00
ScPharmaceuticals (SCPH) United States $0.168B 0.00
Genelux (GNLX) United States $0.166B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.161B 0.00
Third Harmonic Bio (THRD) United States $0.161B 0.00
Greenwich LifeSciences (GLSI) United States $0.158B 0.00
BioAge Labs (BIOA) United States $0.158B 0.00
Cidara Therapeutics (CDTX) United States $0.158B 0.00
Instil Bio (TIL) United States $0.157B 0.00
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Actuate Therapeutics (ACTU) United States $0.153B 0.00
Nkarta (NKTX) United States $0.152B 0.00
Sutro Biopharma (STRO) United States $0.151B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Nuvectis Pharma (NVCT) United States $0.145B 0.00
Invivyd (IVVD) United States $0.145B 0.00
Inventiva S.A (IVA) France $0.144B 0.00
Puma Biotechnology (PBYI) United States $0.143B 6.08
TuHURA Biosciences (HURA) United States $0.140B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.139B 0.00
Seres Therapeutics (MCRB) United States $0.139B 0.00
2seventy Bio (TSVT) United States $0.138B 0.00
Seer (SEER) United States $0.135B 0.00
Renovaro (RENB) United States $0.134B 0.00
Biomea Fusion (BMEA) United States $0.132B 0.00
Black Diamond Therapeutics (BDTX) United States $0.129B 0.00
Caribou Biosciences (CRBU) United States $0.128B 0.00
Coherus BioSciences (CHRS) United States $0.127B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.127B 0.00
InflaRx (IFRX) Germany $0.124B 0.00
Sagimet Biosciences (SGMT) United States $0.123B 0.00
Kyverna Therapeutics (KYTX) United States $0.123B 0.00
Vigil Neuroscience (VIGL) United States $0.118B 0.00
Ventyx Biosciences (VTYX) United States $0.117B 0.00
TScan Therapeutics (TCRX) United States $0.117B 0.00
TELA Bio (TELA) United States $0.112B 0.00
Elutia (ELUT) United States $0.111B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.110B 0.00
Invizyne Technologies (EXOZ) United States $0.109B 0.00
Immunic (IMUX) United States $0.106B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
Cabaletta Bio (CABA) United States $0.102B 0.00
Akoya Biosciences (AKYA) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.102B 0.00
Alpha Cognition (ACOG) Canada $0.101B 0.00
Rani Therapeutics Holdings (RANI) United States $0.099B 0.00
CAMP4 Therapeutics (CAMP) United States $0.097B 0.00
Climb Bio (CLYM) United States $0.097B 0.00
Vor Biopharma (VOR) $0.096B 0.00
XBiotech (XBIT) United States $0.095B 0.00
Skye Bioscience (SKYE) United States $0.095B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.095B 0.00
Zura Bio (ZURA) United States $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Jasper Therapeutics (JSPR) United States $0.092B 0.00
Galena Biopharma (SLS) United States $0.092B 0.00
Artiva Biotherapeutics (ARTV) United States $0.092B 0.00
Adagene (ADAG) China $0.090B 0.00
Tenaya Therapeutics (TNYA) United States $0.090B 0.00
Theratechnologies (THTX) Canada $0.088B 0.00
DBV Technologies S.A (DBVT) France $0.088B 0.00
Elicio Therapeutics (ELTX) United States $0.087B 0.00
BioHarvest Sciences (BHST) Canada $0.087B 0.00
MediciNova (MNOV) United States $0.087B 0.00
Cue Biopharma (CUE) United States $0.087B 0.00
Citius Oncology (CTOR) United States $0.086B 0.00
Cellectis S.A (CLLS) France $0.086B 0.00
Alto Neuroscience (ANRO) United States $0.084B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.083B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Adverum Biotechnologies (ADVM) United States $0.083B 0.00
IGM Biosciences (IGMS) United States $0.083B 0.00
Adicet Bio (ACET) United States $0.082B 0.00
Scilex Holding (SCLX) United States $0.082B 0.00
Inozyme Pharma (INZY) United States $0.082B 0.00
Agenus (AGEN) United States $0.081B 0.00
X4 Pharmaceuticals (XFOR) United States $0.081B 0.00
Adlai Nortye (ANL) Cayman Islands $0.080B 0.00
ZIVO Bioscience (ZIVO) United States $0.080B 0.00
I-Mab (IMAB) China $0.079B 0.00
Entera Bio (ENTX) Israel $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Aligos Therapeutics (ALGS) United States $0.075B 0.00
23andMe Holding (ME) United States $0.074B 0.00
IO Biotech (IOBT) Denmark $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.072B 0.00
Aadi Bioscience (AADI) United States $0.071B 0.00
Ikena Oncology (IKNA) United States $0.070B 0.00
Aerovate Therapeutics (AVTE) United States $0.069B 0.00
Bluebird Bio (BLUE) United States $0.068B 0.00
Forte Biosciences (FBRX) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
VTv Therapeutics (VTVT) United States $0.067B 0.00
Applied Therapeutics (APLT) United States $0.066B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.065B 0.00
Mersana Therapeutics (MRSN) United States $0.065B 0.00
CytomX Therapeutics (CTMX) United States $0.064B 4.80
Quince Therapeutics (QNCX) United States $0.064B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
Shattuck Labs (STTK) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.062B 0.00
BGM Group (BGM) China $0.059B 0.00
ALX Oncology Holdings (ALXO) United States $0.059B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.058B 0.00
Rein Therapeutics (RNTX) United States $0.058B 0.00
Inovio Pharmaceuticals (INO) United States $0.058B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.057B 0.00
Earth Science Tech (ETST) United States $0.056B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Estrella Immunopharma (ESLA) United States $0.054B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.053B 0.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Immuneering (IMRX) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Immix Biopharma (IMMX) United States $0.049B 0.00
Abpro Holdings (ABP) United States $0.049B 0.00
Connect Biopharma Holdings (CNTB) United States $0.048B 0.00
PepGen (PEPG) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Lantern Pharma (LTRN) United States $0.047B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Spero Therapeutics (SPRO) United States $0.046B 11.95
Precision BioSciences (DTIL) United States $0.045B 0.00
FibroBiologics (FBLG) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.045B 0.00
Boundless Bio (BOLD) United States $0.045B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Rapt Therapeutics (RAPT) United States $0.044B 0.00
Medicus Pharma (MDCX) Canada $0.044B 0.00
Atara Biotherapeutics (ATRA) United States $0.043B 0.00
Celularity (CELU) United States $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.042B 0.00
KALA BIO (KALA) United States $0.042B 0.00
Generation Bio (GBIO) United States $0.041B 0.00
Femasys (FEMY) United States $0.041B 0.00
Ovid Therapeutics (OVID) United States $0.040B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.040B 0.00
MiNK Therapeutics (INKT) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.036B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
UNITY Biotechnology (UBX) United States $0.035B 0.00
Grace Therapeutics (GRCE) Canada $0.034B 0.00
Cadrenal Therapeutics (CVKD) United States $0.034B 0.00
Passage Bio (PASG) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
CalciMedica (CALC) United States $0.033B 0.00
Rallybio (RLYB) United States $0.032B 0.00
Pluri (PLUR) Israel $0.032B 0.00
Annovis Bio (ANVS) United States $0.032B 0.00
Equillium (EQ) United States $0.032B 0.00
Cyclo Therapeutics (CYTH) United States $0.031B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Q32 Bio (QTTB) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Enzo Biochem (ENZ) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Onconetix (ONCO) United States $0.027B 0.00
Curis (CRIS) United States $0.026B 0.00
Allakos (ALLK) United States $0.026B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Cognition Therapeutics (CGTX) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.025B 0.00
RenovoRx (RNXT) United States $0.025B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.025B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.025B 0.00
Beyond Air (XAIR) United States $0.024B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
LakeShore Biopharma (LSB) China $0.022B 0.00
Exicure (XCUR) United States $0.022B 0.00
HOOKIPA Pharma (HOOK) United States $0.022B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
NextCure (NXTC) United States $0.021B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
IN8bio (INAB) United States $0.021B 0.00
NKGen Biotech (NKGN) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Senti Biosciences (SNTI) United States $0.019B 0.00
BRIACELL THERAP (BCTX) Canada $0.019B 0.00
Leap Therapeutics (LPTX) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.018B 0.00
OnKure Therapeutics (OKUR) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.018B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Affimed (AFMD) Germany $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
CervoMed (CRVO) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Quantum Biopharma (QNTM) Canada $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
BioAffinity Technologies (BIAF) United States $0.013B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Psyence Biomedical (PBM) Canada $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
Omega Therapeutics (OMGA) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Apollomics (APLM) United States $0.008B 0.00
Dogwood Therapeutics (DWTX) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Hoth Therapeutics (HOTH) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
BioXcel Therapeutics (BTAI) United States $0.007B 0.00
Silo Pharma (SILO) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Ocean Biomedical (OCEA) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
180 Life Sciences (ATNF) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
GENPREX (GNPX) United States $0.003B 0.00
Evaxion Biotech (EVAX) Denmark $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Vincerx Pharma (VINC) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Eyenovia (EYEN) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Pasithea Therapeutics (KTTA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Enveric Biosciences (ENVB) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00